Furthermore, precisely targeting cell types that express eHSP70, such as precisely targeting HUVECs to inhibit angiogenesis promoted by eHSP70 or developing HSP70-pulsed DC vaccines, would make HSP70-based cancer treatment mores stable without affecting normal cell homeostasis or inducing unpredictable responses. Here, HSPA1A is linked to cancer.